Sandip Roy

Sandip Roy currently serves as Vice President and Global Head of Regulatory Affairs & Safety/Pharmacovigilance at Mallinckrodt Pharmaceuticals since October 2022. Previously, Sandip held the position of Head of US Regulatory Affairs & Global Product Strategy at Organon from June 2021 to November 2022. Prior experience includes roles at Merck as Associate Vice President for General Medicine and Executive Director for Vaccines and Infectious Disease in Global Regulatory Affairs, as well as positions at Novartis that encompassed Senior Director of Oncology Drug Regulatory Affairs and Director of Oncology Drug Regulatory Affairs. Sandip's early career includes leadership roles at 3M and experience as a Clinical Pharmacologist at the FDA. Academic credentials include a Fellowship in Clinical Pharmacology from the University of Chicago, a Ph.D. in Public Health from the University of South Florida, and a B.S. in Pharmacy from Jadavpur University.